A tophus (plural tophi) is an organized deposit of monosodium urate crystals surrounded by inflammatory tissue. It is a characteristic manifestation of gout, a disease caused by urate crystal deposition. Tophi may form beneath the skin, around joints, within tendons, and in other tissues. Although often painless, they can cause joint damage, deformity, restricted movement, and skin breakdown.
Formation and structure
Tophi develop when sustained elevation of urate in body fluids permits monosodium urate crystals to accumulate. Urate is the principal end product of purine breakdown in humans. Its concentration reflects both production and elimination, particularly excretion through the kidneys. Reduced urate excretion is a common contributor to gout; chronic kidney disease can increase this tendency.
Crystal deposits provoke persistent inflammation. A mature tophus contains a central accumulation of crystals surrounded by macrophages, multinucleated giant cells, and an outer zone of connective tissue. It is therefore not simply an inert lump of crystals, but a structured lesion involving an ongoing tissue response.
Tophi generally reflect a substantial, prolonged urate burden. They commonly occur after years of gout, although they can occasionally be recognized before a clear history of acute gout attacks. Not everyone with elevated blood urate develops gout or tophi.
Appearance and distribution
Superficial tophi usually appear as firm, irregular nodules. They may be skin-coloured, yellowish, or white, with chalky material visible through thin overlying skin. Their size ranges from small nodules to large masses.
Common locations include:
- The fingers, toes, and tissues around their joints.
- The outer ear, particularly the helix.
- The bursa over the tip of the elbow.
- The Achilles tendon and other tendons.
- The feet and other sites exposed to pressure or repeated mechanical stress.
Deposits may also occur deep within joints and surrounding tissues without producing an obvious external lump. Less commonly, tophi occur in unusual locations such as the spine.
Tophi can remain relatively painless between inflammatory episodes. Their presence nevertheless indicates established crystal deposition and does not depend on whether a joint is currently red, swollen, or painful.
Diagnosis
Diagnosis combines the clinical appearance and distribution of lesions with the history of gout, laboratory findings, and, when needed, examination of material from a deposit.
Identification of needle-shaped, strongly negatively birefringent monosodium urate crystals by compensated polarized light microscopy provides definitive evidence of urate deposition. Material may be obtained by aspiration of a tophus or an affected joint. A biopsy can help distinguish an atypical mass from other lesions. In routine tissue processing, urate crystals may dissolve, leaving characteristic spaces surrounded by an inflammatory reaction.
Blood urate measurement supports assessment of the underlying disorder but cannot by itself establish that a nodule is a tophus. A single normal urate measurement, especially during an acute gout flare, does not exclude gout.
Imaging helps define deposits and associated damage:
- Ultrasonography can demonstrate tophi and other features of urate deposition.
- Radiography may show soft-tissue masses and characteristic bone erosions in established disease.
- Dual-energy computed tomography can identify deposits with material characteristics consistent with urate, although artifacts and small deposits can limit interpretation.
The differential diagnosis includes nodules associated with rheumatoid arthritis, calcified deposits, cysts, infection, and other soft-tissue masses.
Complications and clinical significance
Tophi can erode adjacent bone and damage joint structures. Large deposits may interfere with tendon movement, impair hand function or walking, and compress nearby nerves. Deposits close to the skin can ulcerate and discharge chalky material; secondary infection may complicate an open lesion.
The size and number of visible tophi do not fully represent the total crystal burden, because substantial deposits may lie beneath the surface. Tophus shrinkage is one measure used to assess response to long-term gout treatment.
Treatment and course
Management addresses the underlying urate burden as well as local complications. Sustained urate-lowering treatment can gradually dissolve crystal deposits and reduce tophus size. Resolution often takes months to years, depending on the initial deposit burden and the degree and duration of urate reduction.
Medicines used to control an acute inflammatory flare relieve inflammation but do not, by themselves, remove established deposits. Surgery is sometimes used for selected complications, including severe mechanical impairment, nerve compression, or problematic ulceration. Removal of an individual mass does not correct the underlying tendency to deposit urate, and lesions can recur if that tendency persists.